About LakeShore Biopharma Co., Ltd. (LSBCF) data
Data as of June 15, 2026.
LakeShore Biopharma Co., Ltd. (LSBCF) has 4.08K shares sold short as of the latest FINRA settlement report on June 15, 2026. Short interest has increased by 0.00% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.65 days (days to cover).
Recent LSBCF short interest history
| Settlement date | Short interest | Change | Days to cover |
|---|---|---|---|
| Jun 15, 2026 | 4,076 | 0.00% | 1.00 |
| May 29, 2026 | 4,076 | 0.00% | 1.00 |
| May 15, 2026 | 4,076 | 0.00% | 1.86 |
| Apr 30, 2026 | 4,076 | -0.07% | 1.60 |
| Apr 15, 2026 | 4,079 | -0.58% | 1.00 |
| Mar 31, 2026 | 4,103 | -0.07% | 1.91 |
| Mar 13, 2026 | 4,106 | -0.05% | 1.00 |
| Feb 27, 2026 | 4,108 | -0.02% | 1.00 |
| Feb 13, 2026 | 4,109 | 0.00% | 1.00 |
| Jan 30, 2026 | 4,109 | 0.00% | 1.00 |
| Jan 15, 2026 | 4,109 | -8.93% | 1.00 |
| Dec 31, 2025 | 4,512 | 9.73% | 1.37 |
Full history, charts, and borrow-fee detail are on the LSBCF short interest page.
Frequently asked questions
What is the current short interest in LSBCF?
As of the latest FINRA settlement dated June 15, 2026, LSBCF had approximately 4,076 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short LSBCF?
The latest borrow fee (cost to borrow) for LSBCF is 23.92% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for LSBCF?
Days to cover for LSBCF is approximately 0.65 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is LSBCF a short squeeze candidate?
A squeeze needs shorts that are hard to close. LSBCF trades about 6,249 shares a day and would take roughly 0.65 days to unwind current short positions, at a current borrow fee of 23.92%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.